drugset / Trial / NCT02113176

Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage

NCT02113176

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of a drug minocycline in improving outcomes at 3 months after rupture of an aneurysm in the head.

Timeline

Start
2010-01
Primary completion
2016-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 200 mg Intravenous